140 related articles for article (PubMed ID: 11522940)
1. Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer's disease.
Yoshiyama Y; Arai K; Hattori T
Neuroreport; 2001 Aug; 12(12):2641-5. PubMed ID: 11522940
[TBL] [Abstract][Full Text] [Related]
2. Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi.
Shijo M; Honda H; Suzuki SO; Hamasaki H; Hokama M; Abolhassani N; Nakabeppu Y; Ninomiya T; Kitazono T; Iwaki T
Brain Pathol; 2018 Jan; 28(1):58-71. PubMed ID: 27997051
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of GABA A receptor gamma subunits in Alzheimer's disease hippocampus: relationship to neurofibrillary tangle progression.
Iwakiri M; Mizukami K; Ikonomovic MD; Ishikawa M; Abrahamson EE; DeKosky ST; Asada T
Neuropathology; 2009 Jun; 29(3):263-9. PubMed ID: 19019179
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in Alzheimer's disease hippocampus: a topographical study.
Cruz-Sánchez FF; Gironès X; Ortega A; Alameda F; Lafuente JV
J Neurol Sci; 2010 Dec; 299(1-2):163-7. PubMed ID: 20863531
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.
Umahara T; Uchihara T; Tsuchiya K; Nakamura A; Iwamoto T; Ikeda K; Takasaki M
Acta Neuropathol; 2004 Oct; 108(4):279-86. PubMed ID: 15235803
[TBL] [Abstract][Full Text] [Related]
6. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
[TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins.
Layfield R; Fergusson J; Aitken A; Lowe J; Landon M; Mayer RJ
Neurosci Lett; 1996 May; 209(1):57-60. PubMed ID: 8734909
[TBL] [Abstract][Full Text] [Related]
8. Involvement of clathrin light chains in the pathology of Alzheimer's disease.
Nakamura Y; Takeda M; Yoshimi K; Hattori H; Hariguchi S; Kitajima S; Hashimoto S; Nishimura T
Acta Neuropathol; 1994; 87(1):23-31. PubMed ID: 8140893
[TBL] [Abstract][Full Text] [Related]
9. PDGF is associated with neuronal and glial alterations of Alzheimer's disease.
Masliah E; Mallory M; Alford M; Deteresa R; Saitoh T
Neurobiol Aging; 1995; 16(4):549-56. PubMed ID: 8544904
[TBL] [Abstract][Full Text] [Related]
10. The unfolded protein response is activated in Alzheimer's disease.
Hoozemans JJ; Veerhuis R; Van Haastert ES; Rozemuller JM; Baas F; Eikelenboom P; Scheper W
Acta Neuropathol; 2005 Aug; 110(2):165-72. PubMed ID: 15973543
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
12. Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease.
Mei M; Su B; Harrison K; Chao M; Siedlak SL; Previll LA; Jackson L; Cai DX; Zhu X
J Neurochem; 2006 Dec; 99(5):1377-88. PubMed ID: 17064357
[TBL] [Abstract][Full Text] [Related]
13. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.
Rohn TT; Head E; Su JH; Anderson AJ; Bahr BA; Cotman CW; Cribbs DH
Am J Pathol; 2001 Jan; 158(1):189-98. PubMed ID: 11141492
[TBL] [Abstract][Full Text] [Related]
14. G-protein alpha-subunit levels in hippocampus and entorhinal cortex of brains staged for Alzheimer's disease neurofibrillary and amyloid pathologies.
García-Jiménez A; Fastbom J; Ohm TG; Cowburn RF
Neuroreport; 2003 Aug; 14(11):1523-7. PubMed ID: 12960778
[TBL] [Abstract][Full Text] [Related]
15. Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease.
Götz ME; Wacker M; Luckhaus C; Wanek P; Tatschner T; Jellinger K; Leblhuber F; Ransmayr G; Riederer P; Eder E
Neurosci Lett; 2002 May; 324(1):49-52. PubMed ID: 11983292
[TBL] [Abstract][Full Text] [Related]
16. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 and Bax protein expression in Alzheimer's disease.
Tortosa A; López E; Ferrer I
Acta Neuropathol; 1998 Apr; 95(4):407-12. PubMed ID: 9560019
[TBL] [Abstract][Full Text] [Related]
18. Proteins immunologically related to erythrocyte anion transporter band 3 are altered in brain areas affected by Alzheimer's disease.
Bosman GJ; Van Workum FP; Renkawek K; Van Kalmthout PJ; Bartholomeus IG; De Grip WJ
Acta Neuropathol; 1993; 86(4):353-9. PubMed ID: 8256585
[TBL] [Abstract][Full Text] [Related]
19. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB precursor, p105, and NF-kappaB inhibitor, IkappaBgamma, are both elevated in Alzheimer disease brain.
Huang Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
Neurosci Lett; 2005 Jan; 373(2):115-8. PubMed ID: 15567564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
